small molecule

QLOSI

PILOCARPINE HYDROCHLORIDE

Loss of exclusivityAugust 2037latest FDA-listed patent expiry

CompanyOrasis Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand name	QLOSI
Active ingredient	PILOCARPINE HYDROCHLORIDE
Strength	0.4%
Dosage form	SOLUTION/DROPS
Route	OPHTHALMIC
Modality	Small molecule
FDA approval	October 2023
Marketing status	RX

Listed patents

Patent	Expires	Type
11129812	August 2037	use U-3741
10639297	August 2037	product
11974986	August 2037	use U-3741
9867810	August 2037	product

Regulatory exclusivity

Code	Expires
NP	October 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.